EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Pilot Study Exploiting the Industrialization Potential of Solid Lipid Nanoparticle-Based Metered-Dose Inhalers

Lei Shu, Wenhua Wang, Chon-Iong Ng, Xuejuan Zhang, Ying Huang, Chuanbin Wu, Xin Pan, Zhengwei Huang

Pharmaceutics · 07.03.2023 · 15 (3) · 866

DOI: 10.3390/pharmaceutics15030866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.03.2023. Verfasst von Lei Shu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jinan University, Guangzhou 510006, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Delivery of inhalable nanoparticles through metered-dose inhalers (MDI) is a promising approach to treat lung disease such as asthma and chronic obstructive pulmonary disease. Nanocoating of the inhalable nanoparticles helps in stability and cellular uptake enhancement but complicates the production process. Thus, it is meaningful to accelerate the translation process of MDI encapsulating inhalable nanoparticles with nanocoating structure.

Methods

In this study, solid lipid nanoparticles (SLN) are selected as a model inhalable nanoparticle system. An established reverse microemulsion strategy was utilized to explore the industrialization potential of SLN-based MDI. Three categories of nanocoating with the functions of stabilization (by Poloxamer 188, encoded as SLN(0)), cellular uptake enhancement (by cetyltrimethylammonium bromide, encoded as SLN(+)), and targetability (by hyaluronic acid, encoded as SLN(−)) were constructed upon SLN, whose particle size distribution and zeta-potential were characterized. Subsequently, SLN were loaded into MDI, and evaluated for the processing reliability, physicochemical nature, formulation stability, and biocompatibility.

Results

The results elucidated that three types of SLN-based MDI were successfully fabricated with good reproducibility and stability. Regarding safety, SLN(0) and SLN(−) showed negligible cytotoxicity on cellular level.

Conclusions

This work serves as a pilot study for the scale-up of SLN-based MDI, and could be useful for the future development of inhalable nanoparticles.

Schlagwörter

Stichwörter der Autor:innen

inhalationmetered-dose inhalernanocoatingpilot studysolid lipid nanoparticle

Autor:innen und Institutionen

  • College of Pharmacy, Jinan University, Guangzhou 510006, China.
  • School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510275, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Shu, L., Wang, W., Ng, C. I., Zhang, X., Huang, Y., Wu, C., Pan, X., & Huang, Z. (2023). A Pilot Study Exploiting the Industrialization Potential of Solid Lipid Nanoparticle-Based Metered-Dose Inhalers. Pharmaceutics, 15(3), 866. https://doi.org/10.3390/pharmaceutics15030866

Vancouver

Shu L, Wang W, Ng CI, Zhang X, Huang Y, Wu C, et al. A Pilot Study Exploiting the Industrialization Potential of Solid Lipid Nanoparticle-Based Metered-Dose Inhalers. Pharmaceutics. 2023;15(3):866. doi:10.3390/pharmaceutics15030866

BibTeX
@article{Shu2023,
  author = {Shu, Lei and Wang, Wenhua and Ng, Chon-Iong and Zhang, Xuejuan and Huang, Ying and Wu, Chuanbin and Pan, Xin and Huang, Zhengwei},
  title = {A Pilot Study Exploiting the Industrialization Potential of Solid Lipid Nanoparticle-Based Metered-Dose Inhalers},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {866},
  doi = {10.3390/pharmaceutics15030866}
}
Kostenlos starten →